SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-07-048594
Filing Date
2007-08-01
Accepted
2007-08-01 08:39:17
Documents
1
Period of Report
2007-07-31

Document Format Files

Seq Description Document Type Size
1 LATEGAN FORM 3 7/31/07 rrd167279.html 3  
1 LATEGAN FORM 3 7/31/07 rrd167279.xml 3 2884
  Complete submission text file 0001181431-07-048594.txt   4826
Mailing Address 134 COOLIDGE AVE WATERTOWN MA 02472
Business Address 134 COOLIDGE AVE WATERTOWN MA 02472 617-926-1551
PANACOS PHARMACEUTICALS, INC. (Issuer) CIK: 0001040017 (see all company filings)

IRS No.: 113238476 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PANACOS PHARMACEUTICALS, INC. 134 COOLIDGE AVENUE WATERTOWN MA 02472
Business Address 617 779 5599
Lategan Thomas (Reporting) CIK: 0001408202 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-24241 | Film No.: 071014424